Yes, uterine fibroids produce measurable inflammation within the uterus. Fibroid tissue generates higher levels of inflammatory signaling molecules than the surrounding healthy muscle tissue, creating a localized inflammatory environment that can contribute to pain, heavy bleeding, and fertility problems. However, the inflammation appears to be mostly local rather than body-wide, and the relationship runs in both directions: inflammation also appears to fuel fibroid growth.
What Happens Inside Fibroid Tissue
Fibroids aren’t just inert lumps of tissue. They actively produce inflammatory signals that differ from the normal uterine muscle around them. Research using detailed cytokine profiling found that fibroid tissue has significantly higher levels of IL-1 alpha, a molecule closely tied to inflammation, blood vessel formation, and immune cell activation. At the same time, fibroids produce significantly less of the molecule that naturally counteracts IL-1 alpha (called IL-1RA), essentially removing the brake on that inflammatory signal.
Fibroids also overproduce a growth factor called TGF-beta, particularly the TGF-beta 3 form. This protein does double duty: it drives inflammation and it causes the fibroid to build up excessive amounts of structural tissue, including collagen, fibronectin, and other fibrous proteins. That buildup of stiff, fibrous material is actually what makes a fibroid feel firm and dense. TGF-beta also slows down the enzymes that would normally break down this excess tissue, so the structural material keeps accumulating. This is why fibroids are sometimes described as fibrotic tumors rather than purely muscular growths.
Local Inflammation, Not Necessarily Systemic
One important distinction: the inflammation fibroids create appears to stay largely within the uterus rather than spreading throughout the body. A national study using data from over a thousand U.S. women found no meaningful link between having fibroids and elevated C-reactive protein (CRP), a standard blood marker of body-wide inflammation. This was a notable contrast to endometriosis, which was associated with 60% higher odds of elevated CRP.
So if your doctor has tested your CRP or other general inflammatory markers and they came back normal, that doesn’t mean your fibroids aren’t causing local problems. The inflammation is concentrated in the uterine tissue itself, where it can still cause significant symptoms.
How This Inflammation Drives Pain
Fibroid-related pelvic pain isn’t just from the physical bulk of the tumor pressing on surrounding structures. Inflammation plays a direct role in how nerve fibers respond. Research has found that women with painful fibroids have nerve fibers present in layers of the uterine lining where they don’t normally appear. These extra nerve fibers, detected in both the inner lining and the muscle wall, were found in women experiencing pain but not in pain-free women.
The inflammatory environment likely sensitizes these nerve fibers, lowering the threshold for pain signals. Stress hormones can worsen this cycle: norepinephrine, released during chronic stress, promotes the production of more inflammatory molecules through pathways that amplify both inflammation and cell growth. This may partly explain why stress and fibroid symptoms often feel connected.
The Two-Way Relationship With Oxidative Stress
Fibroids don’t just produce inflammation. They also create oxidative stress, a condition where damaging molecules called reactive oxygen species outnumber the body’s protective antioxidants. Fibroid tissue shows higher levels of oxidative stress markers compared to normal uterine muscle, and this imbalance feeds back into the inflammatory cycle.
Oxidative stress in fibroid tissue triggers a process called autophagy, the cell’s recycling system, which becomes dysregulated. Markers of this recycling process correlate strongly with both oxidative stress markers and inflammatory molecules like TNF-alpha and TGF-beta 3. The result is a self-reinforcing loop: inflammation generates oxidative stress, which disrupts normal cell maintenance, which promotes more inflammation and further fibroid growth. Visceral fat (the fat stored around internal organs) adds fuel to this cycle by producing its own chronic, low-grade inflammation that may promote cell growth in fibroids.
Effects on Fertility and Implantation
For women trying to conceive, the local inflammation from fibroids can directly interfere with embryo implantation. Fibroids that push into or sit near the uterine cavity are the most disruptive. They reduce expression of key implantation genes called HOXA10 and HOXA11, and this reduction isn’t limited to the tissue directly beneath the fibroid. It affects the entire uterine lining, suggesting that inflammatory signals diffuse outward from the tumor.
The mechanism works like this: excess TGF-beta 3 from the fibroid blocks receptors that normally respond to a growth factor critical for implantation (BMP-2). Without that signal, the lining can’t properly prepare for an embryo. The fibroid also physically compresses nearby tissue, creating areas of reduced blood flow and lower oxygen levels. This triggers increased blood vessel formation and draws in more immune cells, particularly macrophages, which further alter the inflammatory landscape of the lining. Macrophage density is significantly higher in uterine lining tissue close to a fibroid than in tissue farther away, regardless of the fibroid’s size.
TNF-alpha, another inflammatory molecule associated with fibroids, can independently disrupt implantation when its levels become abnormal. Together, these changes create a hostile environment during the window when an embryo would normally attach, contributing to both difficulty conceiving and early pregnancy loss.
What May Help Reduce Fibroid-Related Inflammation
Because inflammation and oxidative stress work together to promote fibroid growth, strategies that address both may help manage symptoms and slow progression. Dietary patterns high in processed foods, red meat, and added sugars are associated with hormonal imbalances, inflammation, and oxidative stress that can promote fibroid growth.
Several specific supplements have shown enough promise that researchers consider them reasonable options for long-term use, particularly for women trying to prevent recurrence after fibroid removal. Vitamin D at 4,000 IU per day and green tea extract (EGCG) at 800 mg per day are the two most commonly cited. Milk thistle, an herb containing the compound silymarin, has established antioxidant and anti-inflammatory properties that may also be relevant, though the evidence is less direct.
These approaches target the inflammatory and oxidative environment rather than shrinking fibroids themselves. They work best as part of a broader management plan, not as standalone treatments for large or symptomatic fibroids. Reducing visceral fat through regular physical activity may also help by lowering the chronic background inflammation that promotes fibroid cell growth.